Outpatient Anal Cancer Screening in the Era of COVID-19
Joel Palefsky, MD, FRCP(C)
Professor of Medicine
University of California, San Francisco
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2020. All rights reserved.
Dr. Palefsky completed his MD and residency in Internal Medicine at McGill University and his fellowship in Infectious Diseases at Stanford University. He then joined the faculty at the University of California, San Francisco, where he remains to this day.
An international expert on the molecular biology, treatment, pathogenesis, and natural history of anogenital HPV infections, particularly in the setting of HIV, he is the director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic Research and Education Center at the UCSF Cancer Center.
At the completion of this educational session, learners will:
- Describe the epidemiology of anal HPV infection, high-grade squamous intraepithelial lesions (HSIL) and cancer among people living with HIV (PLWH)
- Describe the progress of the ANCHOR Study
- Describe recent advances in screening for anal cancer and HSIL
- Describe the impact of screening for and treating HSIL in the setting of the COVID pandemic
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation
Download Article PDF/Slides